Devil and Dr. Fauci e-bog
209,76 DKK
(inkl. moms 262,20 DKK)
The Devil and Dr. Fauci is an unsparing critique of what author James Driscoll calls the Drug Testing, Licensing, and Marketing Complex, or DTLM. Quietly dominating Americas healthcare industry, the DTLM poses threats comparable in magnitude, if not in character, to those of the Military-Industrial Complex. With a satiric scalpel reminiscent of Jonathan Swifts, Driscoll eviscerates the DTLMs av...
E-bog
209,76 DKK
Forlag
Academica Press
Udgivet
15 oktober 2021
Længde
152 sider
Genrer
JFFH
Sprog
English
Format
epub
Beskyttelse
LCP
ISBN
9781680537499
The Devil and Dr. Fauci is an unsparing critique of what author James Driscoll calls the Drug Testing, Licensing, and Marketing Complex, or DTLM. Quietly dominating Americas healthcare industry, the DTLM poses threats comparable in magnitude, if not in character, to those of the Military-Industrial Complex. With a satiric scalpel reminiscent of Jonathan Swifts, Driscoll eviscerates the DTLMs avatar Dr. Anthony Fauci, our ages version of the archetypal Dr. Faustus. He exposes Faucis pivotal position in the DTLM, at whose core is the U.S. Food and Drug Administration. The FDA, Driscoll asserts, has long played Mephistopheles to Faucis Faustus, with grave consequences for American healthcare. Dr. Driscolls book is the first to upbraid the DTLM, FDA, and Fauci for exacerbating the Covid-19 crisis. Seeking to maximize profits from patentable vaccines, they rigorously suppressed off patent prophylaxis and treatment alternatives. This was but one of many DTLM follies that raised Covids death toll and increased its socio-economic devastation. Other prominent follies were the mask posturing, arbitrary lockdowns, and closing of churches and schools that the DTLM and its political allies used to distract from their sacrifice of public health to their own agendas. We may never know if the Chinese deliberately released the Covid-19 virus, or if they created it. Yet the world now knows the destructive potential of gain of function technology. Similar epidemics or worse will strike us. To survive next time, we will need radical reforms in the FDA and transparency for the DTLM. But the opaque FDA bureaucracy, Driscoll concludes, is only one instance in our greater problem of deficient oversight within all of our increasingly powerful and ever less accountable federal bureaucracies.